Skip to main content


  1. Authors: Ankit Verma, Anna Shteinfer-Kuzmine, Nikita Kamenetsky, Srinivas Pittala, Avijit Paul, Edna Nahon Crystal, Alberto Ouro, Vered Chalifa-Caspi, Swaroop Kumar Pandey, Alon Monsonego, Noga Vardi, Shira Knafo and Varda Shoshan-Barmatz

    The Correction to this article has been published in Translational Neurodegeneration 2023 12:2


Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China 

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Read more

Author posts: Behind the Paper

We welcome our authors to share the stories behind their research on Springer Nature Neuroscience Community

Find out more about the research published in Translational Neurodegeneration by reading our authors' Behind the Paper posts. 

sn community

Affiliated with

Annual Journal Metrics

  • 2023 Citation Impact
    10.8 - 2-year Impact Factor
    11.6 - 5-year Impact Factor
    2.374 - SNIP (Source Normalized Impact per Paper)
    3.371 - SJR (SCImago Journal Rank)

    2023 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage
    3,389 Altmetric mentions